CAMBRIDGE, Mass., Aug. 21, 2025 (GLOBE NEWSWIRE) -- Cullinan Therapeutics, Inc. (Nasdaq: CGEM; “Cullinan”), a biopharmaceutical company focused on developing modality-agnostic targeted therapies, today announced its participation in the following upcoming investor conferences:
Cullinan Therapeutics to Participate in Upcoming Investor Conferences
Seeking Alpha / 17 hours ago 2 Views
Comments